Publications by authors named "Akemi Miyagawa"
Health and Medical Issues in the Area Affected by Fukushima Daiichi Nuclear Power Plant Accident.
Int J Environ Res Public Health
December 2021
Futaba County was the area most affected by the 2011 Fukushima Daiichi nuclear power plant accident. To understand issues around the re-development of the medical system, we investigated the post-accident changes in medical needs and the system's transition. We analyzed reports from Fukushima Prefecture and local municipalities, ambulance transport data from the Futaba Fire Department, and patient data from Futaba Medical Center (FMC).
View Article and Find Full Text PDFBackground: The Great East Japan Earthquake triggered accidents at the Fukushima Daiichi Nuclear Power Plant, becoming the first complex disaster that included both a natural and a nuclear power disaster. This study examines how complex disasters affect patients with dementia.
Methods: Participants included the 331 people diagnosed with dementia out of the 2482 new patients (between January 2008 and December 2015) at a psychiatric hospital located in the indoor sheltering zones nearby mandatory evacuation zones.
Article Synopsis
- A man initially diagnosed with dementia after the Great East Japan Earthquake presented memory impairment, but further tests revealed no clear evidence of dementia or other mental health issues.
- The patient experienced extreme trauma by witnessing his wife's death in a tsunami and being separated from his family, leading to the suspicion of dissociative disorder affecting his memory.
- Switching to treatments focused on emotional support resulted in gradual improvement of his memory, highlighting the need to consider dissociative disorders in trauma cases involving memory issues.
Background: We investigated a high-throughput and high-precision forward ABO blood typing screening method that utilizes a general-purpose biochemical analyzer to perform direct red blood cell sampling.
Methods: The blood group antisera used were Ortho® BioClone® Anti-A Serum and Ortho® BioClone® Anti-B Se-rum. AFFIRMAGEN® Reagent Red Blood Cells (Ortho Clinical Diagnostics) were used for AB standard red blood cells.